Skip to main content
. 2021 Apr 1;2021:8898887. doi: 10.1155/2021/8898887

Table 1.

Subject characteristics.

Healthy controls (n = 241) Parkinson's disease (n = 489) SWEDD (n = 81)
Age at study entry (mean ± SD) 60.3 ± 11.2 61.1 ± 9.7 60.4 ± 9.9
Age at disease onset (mean ± SD) 59.7 ± 10.0 58.7 ± 10.4

Gender n (%)
Female 84 (34.9) 175 (35.8) 35.8 (29)
Male 157 (65.1) 314 (64.2) 64.2 (52)

Ethnicity n (%)
Caucasian 226 (90.8) 459 (90.9) 78 (92.9)
African American 12 (4.8) 7 (1.4) 1 (1.2)
Hispanic 7 (2.8) 10 (2.0) 2 (2.4)
Asian 1 (0.4) 14 (2.8) 1 (1.2)
Indian/Alaska native 1 (0.4) 4 (0.8) 1 (1.2)
Not specified 2 (0.8) 11 (2.2) 1 (1.2)

Handedness n (%)
Left 24 (12) 40 (9.3) 10 (15.2)
Right 165 (82.5) 380 (88.2) 53 (80.3)
Ambidextrous 11 (5.5) 11 (2.6) 3 (4.5)

Laterality of motor predominance n (%)
Female
Left 75 (50.3) 4 (16.7)
Right 73 (49.0) 19 (79.2)
Bilateral 1 (0.7) 1 (4.2)
Male
Left 107 (37.9) 12 (28.6)
Right 165 (58.5) 26 (61.9)
Bilateral 10 (3.5) 4 (9.5)

Hoehn and Yahr stage n (%)
Stage 0 196 (99.0) 0 0
Stage I 2 (1.0) 187 (43.5) 38 (57.6)
Stage II 0 241 (56.0) 27 (40.9)
Stage III 0 2 (0.5) 1 (1.5)

Demographic data for all subjects. SWEDD = scans without evidence of dopaminergic degeneration.